As in vivo cell therapies enter clinical trials, suppliers tackle the technical and logistical barriers to commercial ...

The acquisition helps diversify UCB’s small molecule-centric arsenal of seizure treatments with a potentially one-off therapy ...

Individual experimental treatment attempt at Hopp Children’s Cancer Center Heidelberg (KiTZ) and Heidelberg University ...

A single-center real-world study compares the effectiveness and toxicity of chimeric antigen receptor T-cell therapy vs ...

Chimeric antigen receptor T-cell therapy (CAR T) has revolutionized oncology treatment over the last decade, offering targeted therapy options for several difficult cancers, espec ...

Once built to fight cancer, CAR‑T therapy is now offering new hope for patients with severe autoimmune disease.

A stem cell therapy with potential disease-modifying effects for feline osteoarthritis (OA) is underway.

The dosing of these two patients demonstrates Cellares’ GMP manufacturing and supply chain capabilities with their automated platform.

High co-payments for potentially curative cell and gene therapies create avoidable access barriers; value-based insurance ...

A few transplant patients in a small study were able to stop using immunosuppressive drugs, thanks to pre-transplant cell ...

STOCKHOLM, 18th April, 2026 (WAM) -- Researchers at Karolinska Institutet and KTH Royal Institute of Technology have ...

CAR-T cell therapy has spread into earlier lines of care over the last ten years, going beyond heavily pretreated populations ...